Health & Life Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	441.84	706.39	601.17	797.54	811.88	774.16
Revenue Growth (YoY)	-33.17%	17.50%	-24.62%	-1.77%	4.87%	83.81%
Cost of Revenue	342.53	558.65	508.07	699.82	766.12	647.09
Gross Profit	99.31	147.74	93.11	97.73	45.76	127.06
Selling, General & Admin	124.17	126.88	116.95	125.47	119.84	122.49
Research & Development	20.19	18.35	16.16	17.34	22.81	21.33
Operating Expenses	144.33	145.24	134.17	142.11	142.65	143.84
Operating Income	-45.02	2.5	-41.06	-44.39	-96.89	-16.78
Interest Expense	-6.1	-3.38	-5.27	-3.14	-3.08	-3.13
Interest & Investment Income	4.27	2.43	2.26	0.78	1.95	0.98
Currency Exchange Gain (Loss)	-7.72	19.15	3.91	22.79	24.28	-2.32
Other Non Operating Income (Expenses)	7.46	7.65	2.6	6.96	-7.56	5.61
EBT Excluding Unusual Items	-47.11	28.35	-37.57	-17	-81.3	-15.64
Gain (Loss) on Sale of Investments	-0.38	-0.02	-	-	-	-
Gain (Loss) on Sale of Assets	-	0.06	0.01	1.45	-	280.15
Legal Settlements	-	-	-	-	-2	-
Other Unusual Items	0	0.39	-	0.09	-	-
Pretax Income	-47.49	28.78	-37.56	-15.47	-83.3	264.52
Income Tax Expense	-1.7	4.54	-4.33	2.08	-20.96	58.54
Net Income	-45.79	24.24	-33.23	-17.55	-62.34	205.98
Net Income to Common	-45.79	24.24	-33.23	-17.55	-62.34	205.98
Shares Outstanding (Basic)	47	47	47	47	47	47
Shares Outstanding (Diluted)	47	47	47	47	47	48
Shares Change (YoY)	-	-	-	-	-0.21%	0.21%
EPS (Basic)	-0.97	0.51	-0.70	-0.37	-1.31	4.34
EPS (Diluted)	-1.00	0.48	-0.70	-0.37	-1.31	4.34
Free Cash Flow	31.64	30.25	76.94	-85.44	-143.53	-56.72
Free Cash Flow Per Share	0.67	0.64	1.62	-1.80	-3.03	-1.19
Gross Margin	22.48%	20.91%	15.49%	12.25%	5.64%	16.41%
Operating Margin	-10.19%	0.35%	-6.83%	-5.56%	-11.93%	-2.17%
Profit Margin	-10.36%	3.43%	-5.53%	-2.20%	-7.68%	26.61%
Free Cash Flow Margin	7.16%	4.28%	12.80%	-10.71%	-17.68%	-7.33%
EBITDA	-29.91	14.5	-29.21	-34.51	-89.91	-7.91
EBITDA Margin	-6.77%	2.05%	-4.86%	-4.33%	-11.07%	-1.02%
D&A For EBITDA	15.11	12.01	11.85	9.87	6.98	8.87
EBIT	-45.02	2.5	-41.06	-44.39	-96.89	-16.78
EBIT Margin	-10.19%	0.35%	-6.83%	-5.56%	-11.93%	-2.17%
Effective Tax Rate	-	15.77%	-	-	-	22.13%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.